Skip to main content
Top
Published in: BMC Infectious Diseases 1/2022

Open Access 01-12-2022 | Hepatitis C | Research

A time series analysis of detection and mortality of hepatitis C in Brazil, 2008–2018

Authors: Rodrigo José Videres Cordeiro de Brito, Leonardo Feitosa da Silva, Márcio Bezerra Santos, Patrícia Muniz Mendes Freire de Moura, Carlos Dornels Freire de Souza, Rodrigo Feliciano do Carmo

Published in: BMC Infectious Diseases | Issue 1/2022

Login to get access

Abstract

Background

The 69th World Health Assembly approved the Global Health Sector Strategy to eliminate hepatitis C virus (HCV) infection by 2030. In Brazil, efforts have been undertaken to achieve this goal; there are, however, great challenges. It is important to understand the disease profile in different regions of the country in order to design strategies to fight the disease nationwide. The objective of this study was to analyse the time trend of the incidence and mortality of hepatitis C in Brazil during the period from 2008 to 2018 according to sociodemographic and clinical characteristics.

Methods

All newly diagnosed cases of hepatitis C reported between 2008 and 2018, in all regions of Brazil, were included. The indicators were obtained from the databases of the Brazilian Ministry of Health. For the time series analysis, a joinpoint regression model was used.

Results

Between 2008 and 2018, 136,759 newly diagnosed cases of hepatitis C were reported considering anti-HCV and HCV RNA positivity, and 271,624 newly diagnosed cases were reported considering one or another positive test. The majority of the records were concentrated in the Southeast (61%) and South (26.2%) Regions. The joinpoint regression model indicated an increasing trend in the detection rate of hepatitis C in Brazil, but there was a decreasing trend in the mortality rate during the period analysed.

Conclusions

Differences were observed in the time trend of hepatitis C and in the sociodemographic and clinical characteristics in different regions of Brazil. These data can provide support to design strategies for the elimination of hepatitis C in Brazil, according to regional particularities.
Literature
2.
go back to reference Pereira LMMB, Martelli CMT, Moreira RC, Merchan-Hamman E, Stein AT, Cardoso MRA, et al. Prevalence and risk factors of Hepatitis C virus infection in Brazil, 2005 through 2009: a cross-sectional study. BMC Infect Dis. 2013;13:60.CrossRef Pereira LMMB, Martelli CMT, Moreira RC, Merchan-Hamman E, Stein AT, Cardoso MRA, et al. Prevalence and risk factors of Hepatitis C virus infection in Brazil, 2005 through 2009: a cross-sectional study. BMC Infect Dis. 2013;13:60.CrossRef
5.
go back to reference Do Carmo RF, de Souza CDF. Impact of the COVID-19 pandemic on hepatitis C diagnosis in Brazil: is the global hepatitis C elimination strategy at risk? J Hepatol. 2021; S0168-8278(21)01999-1. Do Carmo RF, de Souza CDF. Impact of the COVID-19 pandemic on hepatitis C diagnosis in Brazil: is the global hepatitis C elimination strategy at risk? J Hepatol. 2021; S0168-8278(21)01999-1.
7.
go back to reference de Andrade Schramm JM, de Oliveira AF, da Costa LI, Valente JG, Gadelha ÂMJ, Portela MC, et al. Transição epidemiológica e o estudo de carga de doença no Brasil. Cien Saude Colet. 2004;9:897–908.CrossRef de Andrade Schramm JM, de Oliveira AF, da Costa LI, Valente JG, Gadelha ÂMJ, Portela MC, et al. Transição epidemiológica e o estudo de carga de doença no Brasil. Cien Saude Colet. 2004;9:897–908.CrossRef
11.
go back to reference Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335–51.CrossRef Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335–51.CrossRef
12.
go back to reference Hanus JS, Ceretta LB, Simões PW, Uuon L. Incidence of hepatitis C in Brazil. Rev Soc Bras Med Trop. 2015;48:665–73.CrossRef Hanus JS, Ceretta LB, Simões PW, Uuon L. Incidence of hepatitis C in Brazil. Rev Soc Bras Med Trop. 2015;48:665–73.CrossRef
13.
go back to reference Kretzer IF, do Livreamento A, da Cunha J, Gonçalves S, Tosin I, Spada C, et al. Hepatitis C worldwide and in Brazil: silent epidemic–data on disease including incidence, transmission, prevention, and treatment. ScientificWorldJournal. 2014;2014:827849.CrossRef Kretzer IF, do Livreamento A, da Cunha J, Gonçalves S, Tosin I, Spada C, et al. Hepatitis C worldwide and in Brazil: silent epidemic–data on disease including incidence, transmission, prevention, and treatment. ScientificWorldJournal. 2014;2014:827849.CrossRef
14.
go back to reference Victora CG, Barreto ML, do Carmo LM, Monteiro CA, Schmidt MI, Paim J, et al. Lancet Brazil Series Working Group. Health conditions and health-policy innovations in Brazil: the way forward. Lancet. 2011;377(9782):2042–53.CrossRef Victora CG, Barreto ML, do Carmo LM, Monteiro CA, Schmidt MI, Paim J, et al. Lancet Brazil Series Working Group. Health conditions and health-policy innovations in Brazil: the way forward. Lancet. 2011;377(9782):2042–53.CrossRef
15.
go back to reference Marchesini AM, Prá-Baldi ZP, Mesquita F, Bueno R, Buchalla CM. Hepatites B e C em usuários de drogas injetáveis vivendo com HIV em São Paulo, Brasil [Hepatitis B and C among injecting drug users living with HIV in São Paulo, Brazil]. Rev Saude Publica. 2007;41(Suppl 2):57–63.CrossRef Marchesini AM, Prá-Baldi ZP, Mesquita F, Bueno R, Buchalla CM. Hepatites B e C em usuários de drogas injetáveis vivendo com HIV em São Paulo, Brasil [Hepatitis B and C among injecting drug users living with HIV in São Paulo, Brazil]. Rev Saude Publica. 2007;41(Suppl 2):57–63.CrossRef
16.
go back to reference Wolff FH, Fuchs SC, Barcellos NN, de Alencastro PR, Ikeda ML, Brandão AB, et al. Co-infection by hepatitis C virus in HIV-infected patients in southern Brazil: genotype distribution and clinical correlates. PLoS ONE. 2010;5(5):e10494.CrossRef Wolff FH, Fuchs SC, Barcellos NN, de Alencastro PR, Ikeda ML, Brandão AB, et al. Co-infection by hepatitis C virus in HIV-infected patients in southern Brazil: genotype distribution and clinical correlates. PLoS ONE. 2010;5(5):e10494.CrossRef
17.
go back to reference Benzaken AS, Girade R, Catapan E, Pereira GFM, Almeida EC, Vivaldini S, et al. Hepatitis C disease burden and strategies for elimination by 2030 in Brazil. A mathematical modeling approach. Braz J Infect Dis. 2019;23(3):182–90.CrossRef Benzaken AS, Girade R, Catapan E, Pereira GFM, Almeida EC, Vivaldini S, et al. Hepatitis C disease burden and strategies for elimination by 2030 in Brazil. A mathematical modeling approach. Braz J Infect Dis. 2019;23(3):182–90.CrossRef
18.
go back to reference Manns MP, Buti M, Gane E, Pawlotsky JM, Razavi H, Terrault N, et al. Hepatitis C virus infection. Nat Rev Dis Primers. 2017;3:17006.CrossRef Manns MP, Buti M, Gane E, Pawlotsky JM, Razavi H, Terrault N, et al. Hepatitis C virus infection. Nat Rev Dis Primers. 2017;3:17006.CrossRef
20.
go back to reference Spearman CW, Dusheiko GM, Hellard M, Sonderup M. Hepatitis C. Lancet. 2019;394(10207):1451–66.CrossRef Spearman CW, Dusheiko GM, Hellard M, Sonderup M. Hepatitis C. Lancet. 2019;394(10207):1451–66.CrossRef
21.
go back to reference Olmedo DB, Precioso PM, Lugdero-correia A, Da Silva G, Dos Santos AMG. Exposure source prevalence is associated with gender in hepatitis C virus patients from Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz. 2017;112:632–9.CrossRef Olmedo DB, Precioso PM, Lugdero-correia A, Da Silva G, Dos Santos AMG. Exposure source prevalence is associated with gender in hepatitis C virus patients from Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz. 2017;112:632–9.CrossRef
22.
go back to reference Evans JL, Hahn JA, Page-Shafer K, Lum PJ, Stein ES, Davidson PJ, et al. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J Urban Health. 2003;80(1):137–46.CrossRef Evans JL, Hahn JA, Page-Shafer K, Lum PJ, Stein ES, Davidson PJ, et al. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J Urban Health. 2003;80(1):137–46.CrossRef
23.
go back to reference Tracy D, Hahn JA, Fuller Lewis C, Evans J, Briceño A, Morris MD, et al. Higher risk of incident hepatitis C virus among young women who inject drugs compared with young men in association with sexual relationships: a prospective analysis from the UFO Study cohort. BMJ Open. 2014;4(5):e004988.CrossRef Tracy D, Hahn JA, Fuller Lewis C, Evans J, Briceño A, Morris MD, et al. Higher risk of incident hepatitis C virus among young women who inject drugs compared with young men in association with sexual relationships: a prospective analysis from the UFO Study cohort. BMJ Open. 2014;4(5):e004988.CrossRef
24.
go back to reference Esmaeili A, Mirzazadeh A, Carter GM, Esmaeili A, Hajarizadeh B, Sacks HS, et al. Higher incidence of HCV in females compared to males who inject drugs: a systematic review and meta-analysis. J Viral Hepat. 2017;24(2):117–27.CrossRef Esmaeili A, Mirzazadeh A, Carter GM, Esmaeili A, Hajarizadeh B, Sacks HS, et al. Higher incidence of HCV in females compared to males who inject drugs: a systematic review and meta-analysis. J Viral Hepat. 2017;24(2):117–27.CrossRef
25.
go back to reference Gardona R, Appel F, Ercolin S, Carvalho-Filho RJ, Barbosa DA, Ferraz MA. Evaluation of a strategy for identification of hepatitis C virus carriers in outpatient and emergency units: contribution to the microelimination of hepatitis C in Brazil. Braz J Infect Dis. 2021;25(2):101546.CrossRef Gardona R, Appel F, Ercolin S, Carvalho-Filho RJ, Barbosa DA, Ferraz MA. Evaluation of a strategy for identification of hepatitis C virus carriers in outpatient and emergency units: contribution to the microelimination of hepatitis C in Brazil. Braz J Infect Dis. 2021;25(2):101546.CrossRef
26.
go back to reference Toledo AC Jr, Greco DB, Felga M, Barreira D, Gadelha MFS, Speranza FAB. Seroprevalence of hepatitis B and C in Brazilian army conscripts in 2002: a cross-sectional study. Braz J Infect Dis. 2005;9(5):374–83.CrossRef Toledo AC Jr, Greco DB, Felga M, Barreira D, Gadelha MFS, Speranza FAB. Seroprevalence of hepatitis B and C in Brazilian army conscripts in 2002: a cross-sectional study. Braz J Infect Dis. 2005;9(5):374–83.CrossRef
27.
go back to reference de Oliveira-Filho AB, do Socorro Coelho Pimenta A, de Fátima Maciel Rojas M, et al. Likely transmission of hepatitis C virus through sharing of cutting and perforating instruments in blood donors in the State of Pará, Northern Brazil. Cad Saude Publica. 2010;26:837–44.CrossRef de Oliveira-Filho AB, do Socorro Coelho Pimenta A, de Fátima Maciel Rojas M, et al. Likely transmission of hepatitis C virus through sharing of cutting and perforating instruments in blood donors in the State of Pará, Northern Brazil. Cad Saude Publica. 2010;26:837–44.CrossRef
28.
go back to reference Prati D. Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review. J Hepatol. 2006;45:607–16.CrossRef Prati D. Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review. J Hepatol. 2006;45:607–16.CrossRef
29.
go back to reference Schmelzer J, Dugan E, Blach S, Coleman S, Cai Z, DePaola M, et al. Global prevalence of hepatitis C virus in children in 2018: a modelling study. Lancet Gastroenterol Hepatol. 2020;5(4):374–92.CrossRef Schmelzer J, Dugan E, Blach S, Coleman S, Cai Z, DePaola M, et al. Global prevalence of hepatitis C virus in children in 2018: a modelling study. Lancet Gastroenterol Hepatol. 2020;5(4):374–92.CrossRef
30.
go back to reference Oliveira-Filho AB, Santos FJA, Silva FQ, Raiol NC, Costa CCS, Piauiense JNF, et al. Hepatitis C virus infection status and associated factors among a multi-site sample of people who used illicit drugs in the Amazon region. BMC Infect Dis. 2019;19(1):634.CrossRef Oliveira-Filho AB, Santos FJA, Silva FQ, Raiol NC, Costa CCS, Piauiense JNF, et al. Hepatitis C virus infection status and associated factors among a multi-site sample of people who used illicit drugs in the Amazon region. BMC Infect Dis. 2019;19(1):634.CrossRef
31.
go back to reference Gusmão KE, Dias FCF, De Santana VMX, Calado EJR, Oliveira VS, Oliveira AA, et al. Perfil clínico-epidemiológico da hepatite C na região norte do Brasil entre 2012 e 2015. Revista de Patologia do Tocantins. 2017;4(2):41–5.CrossRef Gusmão KE, Dias FCF, De Santana VMX, Calado EJR, Oliveira VS, Oliveira AA, et al. Perfil clínico-epidemiológico da hepatite C na região norte do Brasil entre 2012 e 2015. Revista de Patologia do Tocantins. 2017;4(2):41–5.CrossRef
32.
go back to reference Possuelo LG, Perin D, Breunig PF, Schroeder DF, Allgayer MF, Darsie C, et al. Hepatitis C: evaluation of outcomes and georeferencing of cases in Santa Cruz do Sul, Brazil, between 2002 and 2015. A cross-sectional study. Sao Paulo Med J. 2017;136(2):109–15.CrossRef Possuelo LG, Perin D, Breunig PF, Schroeder DF, Allgayer MF, Darsie C, et al. Hepatitis C: evaluation of outcomes and georeferencing of cases in Santa Cruz do Sul, Brazil, between 2002 and 2015. A cross-sectional study. Sao Paulo Med J. 2017;136(2):109–15.CrossRef
33.
go back to reference Nutini MFR, Hunter J, Giron L, Pires AFNPC, Kohiyama IM, Camargo M, et al. HCV genotype profile in Brazil of mono-infected and HIV co-infected individuals: A survey representative of an entire country. PLoS ONE. 2020;15(1):e0227082.CrossRef Nutini MFR, Hunter J, Giron L, Pires AFNPC, Kohiyama IM, Camargo M, et al. HCV genotype profile in Brazil of mono-infected and HIV co-infected individuals: A survey representative of an entire country. PLoS ONE. 2020;15(1):e0227082.CrossRef
35.
go back to reference Sheu MJ, Liang FW, Lin CY, Lu TH. Changes in liver-related mortality by etiology and sequelae: underlying versus multiple causes of death. Popul Health Metr. 2021;19(1):22.CrossRef Sheu MJ, Liang FW, Lin CY, Lu TH. Changes in liver-related mortality by etiology and sequelae: underlying versus multiple causes of death. Popul Health Metr. 2021;19(1):22.CrossRef
36.
go back to reference Sheu MJ, Liang FW, Lu TH. Hepatitis C virus infection mortality trends according to three definitions with special concern for the baby boomer birth cohort. J Viral Hepat. 2021;28(2):317–25.CrossRef Sheu MJ, Liang FW, Lu TH. Hepatitis C virus infection mortality trends according to three definitions with special concern for the baby boomer birth cohort. J Viral Hepat. 2021;28(2):317–25.CrossRef
37.
go back to reference de Souza CDF, Coutinho HS, Costa MM, Magalhães MAFM, Carmo RF. Impact of COVID-19 on TB diagnosis in Northeastern Brazil. Int J Tuberc Lung Dis. 2020;24(11):1220–2.CrossRef de Souza CDF, Coutinho HS, Costa MM, Magalhães MAFM, Carmo RF. Impact of COVID-19 on TB diagnosis in Northeastern Brazil. Int J Tuberc Lung Dis. 2020;24(11):1220–2.CrossRef
38.
go back to reference Matos TS, do Nascimento VA, do Carmo RF, Moreno de Oliveira Fernandes TR, de Souza CDF, da Silva TFA. Impact of the COVID-19 pandemic on the diagnosis of new leprosy cases in Northeastern Brazil, 2020. Int J Dermatol. 2021;60(8):1003–6.CrossRef Matos TS, do Nascimento VA, do Carmo RF, Moreno de Oliveira Fernandes TR, de Souza CDF, da Silva TFA. Impact of the COVID-19 pandemic on the diagnosis of new leprosy cases in Northeastern Brazil, 2020. Int J Dermatol. 2021;60(8):1003–6.CrossRef
39.
go back to reference Melo APS, França EB, Malta DC, Garcia LP, Mooney M, Naghavi M. Mortality due to cirrhosis, liver cancer, and disorders attributed to alcohol use: global Burden of Disease in Brazil, 1990 and 2015. Rev Bras Epidemiol. 2017;20(Suppl 01):61–74.CrossRef Melo APS, França EB, Malta DC, Garcia LP, Mooney M, Naghavi M. Mortality due to cirrhosis, liver cancer, and disorders attributed to alcohol use: global Burden of Disease in Brazil, 1990 and 2015. Rev Bras Epidemiol. 2017;20(Suppl 01):61–74.CrossRef
Metadata
Title
A time series analysis of detection and mortality of hepatitis C in Brazil, 2008–2018
Authors
Rodrigo José Videres Cordeiro de Brito
Leonardo Feitosa da Silva
Márcio Bezerra Santos
Patrícia Muniz Mendes Freire de Moura
Carlos Dornels Freire de Souza
Rodrigo Feliciano do Carmo
Publication date
01-12-2022
Publisher
BioMed Central
Keyword
Hepatitis C
Published in
BMC Infectious Diseases / Issue 1/2022
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-022-07063-5

Other articles of this Issue 1/2022

BMC Infectious Diseases 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.